NorthWest Biotherapeutics Inc (NWBO)

[thermo]

Yes, but also remember revenue is not shown. Rather revenue * gross margin is shown. And gross margin is typically low when scale is low.

My guess on billing profile:
- an amount is invoiced upon lysate manufacture,
- some additional amounts for shots in 1st year,
- in subsequent years additional amounts for boosters.

this profile will give rapidly increasing gross margin with increasing scale and as new/existing patient mix changes.